Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Total Assets (Quarterly): 173.60M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 173.60M |
| September 30, 2023 | 190.71M |
| June 30, 2023 | 216.14M |
| March 31, 2023 | 243.88M |
| December 31, 2022 | 278.83M |
| September 30, 2022 | 302.13M |
| June 30, 2022 | 323.90M |
| March 31, 2022 | 348.62M |
| Date | Value |
|---|---|
| December 31, 2021 | 366.86M |
| September 30, 2021 | 386.33M |
| June 30, 2021 | 404.66M |
| March 31, 2021 | 386.36M |
| December 31, 2020 | 400.57M |
| September 30, 2020 | 159.20M |
| December 31, 2019 | 77.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
77.60M
Minimum
Dec 2019
404.66M
Maximum
Jun 2021
283.96M
Average
302.13M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| XOMA Corp | 234.30M |
| Societal CDMO Inc (DELISTED) | 153.47M |
| NGM Biopharmaceuticals Inc (DELISTED) | 168.87M |
| Avrobio Inc | 101.09M |
| Landos Biopharma Inc | 38.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.28M |
| Shareholders Equity (Quarterly) | 159.33M |